Skip to main content

Advertisement

Log in

Schwierige Symptomabgrenzung

Depression bei Demenz: Wie gelingt die Behandlung?

  • Zertifizierte Fortbildung
  • Antidepressive Therapie bei Demenz
  • Published:
DNP - Der Neurologe & Psychiater Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Demenzerkrankungen und Depression sind bei älteren Menschen häufig und begünstigen einander.

© sturti / Getty Images / iStock (Symbolbild mit Fotomodellen)

Abb. 1

© Springer-Verlag [4]

Abb. 2

© I. Durgun

Abb. 3
Abb. 4

Literatur

  1. Djernes, JK Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatrica Scandinavica 2006;113:372-87

  2. Weyerer S, Schäufele M. In: Wahl H-W, Brenner H, Rothenbacher D (Hrsg.) The Many Faces of Health, Competence and Well-being in Old Age, Commentary: Medical care for nursing home residents: National perspectives in international context; Dordrecht: Springer, 2006

  3. Ballard C, Bannister C, Solis M et al. The prevalence, associations and symptoms of depression amongst dementia sufferers. J Affect Disord 1996;36:135-44

  4. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59

  5. Rodríguez JJ, Noristani HN, Verkhratsky A. The serotonergic system in ageing and Alzheimer's disease. Prog Neurobiol 2012;99:15-41

  6. Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet 2015;386:1672-82

  7. Franceschi M, Anchisi D, Pelati O et al. Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol 2005;57:216-25

  8. Huey ED, Putnam KT, Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology 2006;66:17-22

  9. Sjögren M, Minthon L, Passant U et al. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging 1998;19:379-84

  10. Murley, Alexander G, and James B Rowe. "Neurotransmitter deficits from frontotemporal lobar degeneration." Brain: a journal of neurology 2018;141:1263-85

  11. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009;8:1006-18

  12. Robinson, Robert G, and Gianfranco Spalletta. Poststroke depression: a review. Canadian journal of psychiatry 2010;55(6):341-9

  13. Aarsland D, Ballard C, Larsen JP et al. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 2001;16:528-36

  14. Jorm AF. Is Depression a Risk Factor for Dementia or Cognitive Decline? Gerontology 2000;46:219-27

  15. Ownby RL, Crocco E, Acevedo A et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63:530-38

  16. Berger AK, Fratiglioni L, Forsell Y et al. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998-2002

  17. Dafsari FS, Jessen F. Depression - an underrecognized target for prevention of dementia in Alzheimer's disease. Transl Psychiatry 2020;10:160

  18. Bassuk SS, Berkman LF, Wypij D. Depressive symptomatology and incident cognitive decline in an elderly community sample. Archives of General Psychiatry 1998;55:1073-81

  19. Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN). S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression 2015, 2. Auflage, Version 5, AWMF-Register-Nr.: nvl-005

  20. Whooley MA et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997;12:439-45

  21. Montgomery SA, Asberg M. A New Depression Scale Designed to be Sensitive to Change. Br J Psychiatry 1979;134:382-9

  22. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49

  23. Ormel J, Oldehinkel AJ, Nolen WA et al. Psychosocial disability before, during, and after a major depressive episode: a 3-wave population-based study of state, scar, and trait effects. Arch Gen Psychiatry 2004;61:387-92

  24. Eaton WW, Shao H, Nestadt G et al. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry 2008;65:513-20

  25. Hardeveld F, Spijker J, De Graaf R et al. Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 2013;43:39-48

  26. Eaton WW, Shao H, Nestadt G et al. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psych 2008;65:513

  27. Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman AT. Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 2013;43:39-48

  28. Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 2003;58:249-65

  29. Judd LL, Rapaport MH, Paulus MP et al. Subsyndromal symptomatic depression: A new mood disorder? Journal Clini Psych 1994;55:18-28

  30. Benkert O, Hippius H (Hrsg.). Kompendium der Psychiatrischen Pharmakotherapie; Springer, 2017

  31. Lange-Asschenfeldt C. Psychopharmakotherapie bei älteren Menschenmit schweren psychischen Erkrankungen. Z Gerontol Geriat 2018;51:770-8

  32. Renom-Guiteras A et al. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. European J Clin Pharmacol 2015;71:861-75

  33. Birks JS, Grimley Evans J. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev 2015;4:CD001191

  34. Matsunaga S, Fujishiro H, Takechi H. Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment: a Systematic Review and Meta-Analysis. J Alzheimers Dis 2019;71:513-23

  35. Spaans HP, Sienaert P, Bouckaert F et al. Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. Br J Psychiatry 2015;206:67-71

  36. Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry 2014;4:33-54

  37. Baltes, Paul B, Baltes MM. Erfolgreiches Altern: Mehr Jahre und mehr Leben. In: Margret M. Baltes, Martin Kohli und Klaus Sames (Hrsg.). Erfolgreiches Altern: Bedingungen und Variationen. Bern: Huber, S. 5-10

  38. Butler RN. The life review: an interpretation of reminiscence in the aged. Psychiatry 1963;26:65-76

  39. Pinquart M, Duberstein PR, Lyness JM. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. Am J Psychiatry 2006;163:1493-501

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließen. Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Durgun, I., Falck, J. & Peters, O. Depression bei Demenz: Wie gelingt die Behandlung?. DNP 22, 43–51 (2021). https://doi.org/10.1007/s15202-020-4613-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15202-020-4613-2

Navigation